pharma-company /Medicinal products /Active ingredients

Rx · PZN 10852282, 10852307, 10852299, 10852336

CYRAMZA 10 mg/ml concentrate for preparation of a solution for infusion

German trade nameCYRAMZA 10 mg-ml Konzentrat zur Herstellung einer Infusionslösung

Active ingredientRamucirumabPharmaceutical formConcentrate for solution for infusion

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Average purchase price (B2B)

~ €1,021

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for CYRAMZA 10 mg/ml concentrate for preparation of a solution for infusion.

Review purchasing terms

CYRAMZA 10 mg/ml concentrate for preparation of a solution for infusion contains the active ingredient Ramucirumab and comes as Concentrate for solution for infusion. 4 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days.


Pack sizes · 4 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
108522820.00.0~ €340
108523070.00.0N/A
108522990.00.0~ €1,701
108523360.00.0N/A

CYRAMZA 10 mg/ml concentrate for preparation of a solution for infusion was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across 2 of 4 PZNs.